EUVIMEDEUVIMED entdecken
Crossref

Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659

Sara Cahill, Shriram Ramani, Matthew Finnegan, Heather Learnard, Jennifer Wang, Milka Koupenova, Liraz Shmeul-Galia, Fiachra Humphries

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1392 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Sara Cahill und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The respiratory virus SARS-CoV-2 has posed a significant health burden since its emergence. The virus primarily infects and replicates in epithelial cells in the respiratory tract, but SARS-CoV-2 viral RNA has also been detected in macrophages isolated from patients with COVID-19. However, how SARS-CoV-2 enters macrophages remains unclear.

Methods

To address this gap, we assessed the metabolic changes that SARS-CoV-2 induces in monocyte-derived and tissue resident macrophages and how this affects transcriptional responses and viral entry.

Results

Our studies suggest that SARS-CoV-2 triggers a TLR2-dependent pathway encompassing IRG1, an enzyme that produces the metabolite itaconate, and NRF2, a transcription factor, which is necessary for effective viral entry into macrophages. Through this mechanism, SARS-CoV-2 induces the NRF2 gene target Macrophage associated receptor with collagenous structure (MARCO) for entry. MARCO is a scavenger receptor that is basally expressed by tissue-resident macrophages and facilitates efferocytosis of unopsonized particles and pathogens. MARCO expression increases in macrophages following SARS-CoV-2 treatment in a TLR2, IRG1, and NRF2-dependent manner. Furthermore, SARS-CoV-2 is unable to effectively enter MARCO-deficient macrophages, suggesting that MARCO serves as an alternative viral entry receptor. Our data shows that MARCO is required for pyroptosis following SARS-CoV-2 infection. In vivo, pre-treatment of mice with an anti-MARCO blocking antibody reduces the severity of COVID-19. To understand how MARCO expression is regulated during infection, I determined that anti-viral type I IFN negatively regulates MARCO via inhibition of NRF2.

Conclusion

Together, these novel findings suggest that SARS-CoV-2 metabolically reprograms macrophages to induce MARCO expression and promote viral entry and pyroptosis in the absence of IFN signaling. This work identifies a novel, druggable host-pathogen interaction that dictates the severity of respiratory virus infection. Funding Source NIH/NIAID T32 AI095213 Topic Categories Viral Immunology (VIR)

Zitieren

APA

Cahill, S., Ramani, S., Finnegan, M., Learnard, H., Wang, J., Koupenova, M., Shmeul-Galia, L., & Humphries, F. (2026). Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1392

Vancouver

Cahill S, Ramani S, Finnegan M, Learnard H, Wang J, Koupenova M, et al. Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1392

BibTeX
@article{Cahill2026,
  author = {Cahill, Sara and Ramani, Shriram and Finnegan, Matthew and Learnard, Heather and Wang, Jennifer and Koupenova, Milka and Shmeul-Galia, Liraz and Humphries, Fiachra},
  title = {Macrophage metabolic reprogramming facilitates viral entry and pyroptosis 2307659},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1392}
}
Kostenlos starten →